Sunday, November 29, 2020

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore

COVID-19 vaccine | SII rejects claims of Covishield#39;s adverse effect, threatens to seek damages in excess of Rs 100 crore The volunteer is falsely laying the blame for his medical problems on the trial of COVID-19 vaccine Covishield, said Serum Institute of India

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccine-|-sii-rejects-claimscovishield39s-adverse-effect-threatens-to-seek-damagesexcessrs-100-crore_14538241.html

No comments:

Post a Comment

Small and midcap stocks may face volatility, but long-term returns still strong: Vikas Khemani

​Every day there was some negative news flow, global concern, geopolitical concern, inflation concern, oil prices, commodity, everything was...